Administration of Bifidobacterium breve Improves the Brain Function of Aβ1-42-Treated Mice via the Modulation of the Gut Microbiome
- 2021-05-11
- Clinical Trial
- Nutrients 13(5)
- G. Zhu
- Jianxin Zhao
- Hao Zhang
- Wei Chen
- Gang Wang
- PubMed: 34064762
- DOI: 10.3390/nu13051602
- Low evidence
- Animal Study
*Bifidobacterium breve* CCFM1025 and WX treatment significantly improved synaptic plasticity and increased the concentrations of brain-derived neurotrophic factor (BDNF), fibronectin type III domain-containing protein 5 (FNDC5), and postsynaptic density protein 95 (PSD-95).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes